Bo Zhang

10.6k total citations · 3 hit papers
252 papers, 6.8k citations indexed

About

Bo Zhang is a scholar working on Molecular Biology, Nephrology and Oncology. According to data from OpenAlex, Bo Zhang has authored 252 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 55 papers in Nephrology and 49 papers in Oncology. Recurrent topics in Bo Zhang's work include Pancreatic and Hepatic Oncology Research (28 papers), Renal Diseases and Glomerulopathies (22 papers) and Chronic Kidney Disease and Diabetes (20 papers). Bo Zhang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (28 papers), Renal Diseases and Glomerulopathies (22 papers) and Chronic Kidney Disease and Diabetes (20 papers). Bo Zhang collaborates with scholars based in China, Japan and United States. Bo Zhang's co-authors include Jin Xu, Xianjun Yu, Si Shi, Qingcai Meng, Chen Liang, Jie Hua, Jiang Liu, Wei Wang, Xiaoqi Mao and Yanggang Yuan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Bo Zhang

239 papers receiving 6.7k citations

Hit Papers

Crosstalk between cancer-associated... 2014 2026 2018 2022 2021 2014 2022 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Zhang China 40 2.6k 1.6k 1.1k 939 931 252 6.8k
Gang Liu China 45 3.3k 1.3× 936 0.6× 1.5k 1.4× 907 1.0× 777 0.8× 327 7.1k
Tohru Fukai United States 49 3.8k 1.4× 711 0.4× 731 0.7× 813 0.9× 1.5k 1.6× 107 11.4k
Glenda C. Gobé Australia 51 4.0k 1.5× 859 0.5× 794 0.7× 1.3k 1.3× 865 0.9× 297 11.3k
Nanping Wang China 50 3.9k 1.5× 845 0.5× 1.2k 1.1× 491 0.5× 1.0k 1.1× 167 7.7k
Hui‐Hua Li China 49 3.3k 1.2× 888 0.5× 713 0.6× 747 0.8× 1.1k 1.2× 225 7.7k
Lili Zhou China 49 4.1k 1.6× 578 0.4× 859 0.8× 674 0.7× 711 0.8× 295 8.8k
Catherine Vergely France 42 2.3k 0.9× 850 0.5× 502 0.5× 732 0.8× 676 0.7× 179 7.0k
Hongwei Wang China 44 3.1k 1.2× 1.2k 0.7× 620 0.6× 656 0.7× 1.5k 1.6× 288 7.4k
Shougang Zhuang United States 53 4.8k 1.8× 867 0.5× 661 0.6× 1.1k 1.2× 828 0.9× 213 9.0k
Bernhard Schieffer Germany 40 2.3k 0.9× 841 0.5× 510 0.5× 511 0.5× 1.6k 1.7× 158 6.9k

Countries citing papers authored by Bo Zhang

Since Specialization
Citations

This map shows the geographic impact of Bo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Zhang more than expected).

Fields of papers citing papers by Bo Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Zhang. The network helps show where Bo Zhang may publish in the future.

Co-authorship network of co-authors of Bo Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Zhang. A scholar is included among the top collaborators of Bo Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Zhang. Bo Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rong, Zeyin, Jianhui Yang, Jiang Liu, et al.. (2025). Dense stroma activates the TGF-β1/FBW7 axis to induce metabolic subtype switching in pancreatic cancer. International Journal of Surgery. 111(2). 1891–1903. 4 indexed citations
2.
Zhang, Mingyu, Xiaoxiang Guan, Zheng Dong, et al.. (2025). Targeting Zfp36 to combat cardiac hypertrophy: Insights into ferroptosis pathways. Clinical and Translational Medicine. 15(3). e70247–e70247. 4 indexed citations
3.
Wang, Wei, Jie Hua, Jingyao Zhang, et al.. (2025). SMUG1 promoted the progression of pancreatic cancer via AKT signaling pathway through binding with FOXQ1. Chinese Medical Journal. 138(20). 2640–2656.
5.
Duan, Suyan, Fang Lu, Rui Sun, et al.. (2024). 25(OH)D level and vascular lesion scores in kidney histopathology as risk-stratification tool for predicting renal progression in people with type 2 diabetes. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 18(5). 103037–103037.
6.
Wang, Mei, Ying Yin, Fei Xu, et al.. (2023). Neovascularization directed by CAVIN1/CCBE1/VEGFC confers TMZ-resistance in glioblastoma. Cancer Letters. 582. 216593–216593. 10 indexed citations
7.
Duan, Suyan, Meng Zhou, Lu Fang, et al.. (2023). Triglyceride-glucose index is associated with the risk of chronic kidney disease progression in type 2 diabetes. Endocrine. 81(1). 77–89. 11 indexed citations
8.
Duan, Suyan, Si Chen, Fang Lu, et al.. (2023). Serum 25-hydroxyvitamin D as a predictive biomarker of clinical outcomes in patients with primary membranous nephropathy. Frontiers in Nutrition. 10. 1171216–1171216. 1 indexed citations
9.
Yang, Lei, Song Dong, Xue‐Wu Wei, et al.. (2022). Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma. Journal for ImmunoTherapy of Cancer. 10(2). e003534–e003534. 120 indexed citations breakdown →
11.
Liu, Peihua, Zhi Chen, Yao He, et al.. (2019). PTEN improve renal fibrosis in vitro and in vivo through inhibiting FAK/AKT signaling pathway. Journal of Cellular Biochemistry. 120(10). 17887–17897. 33 indexed citations
12.
13.
Li, Jie, Bo Zhang, Yan Yang, Jian Jin, & Yong Liu. (2018). Aldehyde dehydrogenase 1 as a predictor of the neoadjuvant chemotherapy response in breast cancer. Medicine. 97(34). e12056–e12056. 11 indexed citations
14.
Zhang, Bo, et al.. (2017). Shading, cooling and humidifying effects of urban forests in Harbin City and possible association with various factors.. Shengtaixue zazhi. 36(4). 951. 15 indexed citations
15.
Sun, Guizhi, et al.. (2016). The plasma levels of CST and BCKDK in patients with sepsis. Peptides. 86. 80–84. 5 indexed citations
16.
Chen, Hui, Haotian Lin, Wan Chen, et al.. (2016). Preoperative and postoperative measurements of retinal vessel oxygen saturation in patients with different grades of cataracts. Acta Ophthalmologica. 95(6). e436–e442. 14 indexed citations
17.
Zhang, Xiaohui, Xiao Ma, Meng Zhao, et al.. (2014). H2 and H3 relaxin inhibit high glucose-induced apoptosis in neonatal rat ventricular myocytes. Biochimie. 108. 59–67. 25 indexed citations
18.
Zhang, Bo. (2011). Changes of T Regulatory Cells and Interleukin-10 in Children with Primary Nephrotic Syndrome before and after Treatment Assisted with Huaiqihuang Particles. Testowy IndexCopernicus. 2 indexed citations
19.
Zhang, Bo. (2004). Oxidative Damage Effect on Kidney of Mice Induced by Sulfur Dioxide Inhalation. 1 indexed citations
20.
Zhang, Bo. (2001). The distributive characteristics of Jingyu mineral water field in the Changbaishan area, Jilin province and its suggestion for developmental strategy. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026